The Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Sarcomas in Children


Date
Wednesday, November 16, 2016 - Thursday, November 16, 2017 12:00 AM   Online, IN

Objectives
At the conclusion of this activity, participants should be able to:
  1. Integrate the knowledge of sarcomatosis into their daily practice
  2. Evaluate the eligibility of potential patients for HIPEC therapy
  3. Interpret the sarcomatosis in their patients and understand treatment strategies for sarcomas

Accreditation
Indiana University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Indiana University School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. 

The planning committee and those in a position to control the content of this activity have disclosed no relevant financial relationships.